-

Within3 Announces the Evolution of Industry-First Insights Management Platform

The amplified iteration of the platform transforms the potential for market visibility, research collaboration and business decision-making in life science

CLEVELAND & LONDON--(BUSINESS WIRE)--Within3 announces new enhancements to its industry-first insights management platform for pharmaceutical and medical device companies. With more than 40 engagement applications across the platform, life science organizations can now better understand their markets, increase the volume and diversity of insights, and accelerate decision-making across the drug development lifecycle – in a single, intuitive, and bespoke platform.

Life science organizations need insights to make better business decisions more quickly. Within3's research reveals that 42% of medical affairs professionals said they struggle most with quickly translating information into action – and the industry’s increasing investment in technology to analyze data bears this out.

The platform enhancements are an evolution of the company’s ‘select, connect, discover’ insights management solution launched last September. The new, bespoke experience allows life science companies the clarity they need to answer their most pressing questions, including knowledge of their target market, insight from stakeholders and how to turn that insight into action.

Enhance market understanding

The Within3 Insights Management Platform simplifies the development of tailored market mapping. Dashboards bring prefiltered treatment patterns and locations of HCP influence, as well as identifying influential HCPs for engagement, while customizable definitions of disease communities answer highly specific questions. Year-round social listening, across the most relevant digital conversations, further refines and enhances market understanding.

Gain more – and more diverse – insight

Engagement is the key that unlocks insight, and Within3’s Insights Management Platform brings together technologies to drive powerful communications.

Asynchronous communication capabilities ensure that participant conversations continue across geographies and time zones, facilitated by in-conversation translation of more than 100 languages.

The Within3 Insights Management Platform further enhances participant experiences, with conversation moderation and real-time notation and co-creation of documents.

Deploying the platform’s asynchronous communication and enhanced collaborative capabilities alone will see typical efficiencies of an 80% reduction in travel and related expenses, 50% honoraria cost savings and up to twice the level of engagement and stakeholder participation.

Turn insight into action

Insight is nothing without action. Within3 translates insights using sophisticated analysis – delivered through its Insights Management Platform.

Life science organizations can now easily identify trending concepts using artificial intelligence and natural language processing. The Insights Management Platform also provides access to Within3’s industry leading analytics and customer success teams, optimizing the value of insights – from research and discovery through product launch and beyond.

“Within3 delivers an industry first: this is a platform that will help to accelerate and inform decision making across the entire drug and device development lifecycle,” says Within3 CEO Lance Hill. “Built on the foundations of proven Within3 technologies, the Insights Management Platform solves some of life science’s most persistent challenges: identifying the most influential partners; engaging them more effectively and efficiently; and driving value from insights as never before.”

Follow Within3 on LinkedIn and Twitter.

ABOUT WITHIN3

Within3 is the world leader in life science insights management. Our insights management platform empowers you to understand your market and its key influencers better, gain diverse insights through better stakeholder engagement, and obtain answers more quickly through faster analysis. The insights management platform lets you collaborate anywhere, anytime, in nearly any language. It reveals the influencers and relationships within your disease community through powerful network analytics. And it uses the power of artificial intelligence to unlock trends and sentiments from field team interactions. To learn more about the insights management platform or to request a demo, visit www.within3.com.

Contacts

Within3


Release Summary
Within3 announces new enhancements to its industry-first insights management platform for pharmaceutical and medical device companies.
Release Versions

Contacts

Social Media Profiles
More News From Within3

Within3 and Array Announce Partnership to Set New Standards in Life Science Stakeholder Engagement

LAKEWOOD, Ohio & DENVER--(BUSINESS WIRE)--In a significant move to transform life science stakeholder engagement, Within3 and Array have announced a strategic partnership integrating synchronous and asynchronous insights management. This partnership is driven by recognizing a market gap and the desire to offer clients a single, high-quality tech partner for comprehensive engagement solutions. Within3’s AI-powered insights management platform and Array’s content engagement solution provide pharm...

Within3 Unveils Major Insights Management Platform Enhancements Capable of Eliminating 90% of the Workload Associated with Insights Moderation, Analysis, and Reporting

CLEVELAND--(BUSINESS WIRE)--Within3 today announced a major step forward in delivering business impact through artificial intelligence (AI) in the drug commercialization arena. The company’s updated Insights Management Platform, built on proven AI capabilities and unique to the market, allows life science companies to rethink how they engage audiences, drive insights, and iterate on business strategies. Within3 is expanding its industry-leading group engagement applications suite with an AI-pow...

Within3 and Reuters Health Announce State of Medical Affairs Insights Management Survey Results

CLEVELAND--(BUSINESS WIRE)--Within3 today announced the results of a comprehensive survey of medical affairs professionals across pharmaceutical and biotechnology organizations. Across all survey participants, no single way of approaching data collection and insights generation emerged, representing a significant gap in the practical application in decision-based processes. The survey of managers to C-level medical affairs professionals focused on how teams are capturing, analyzing, and communi...
Back to Newsroom